Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
4
×
biotech
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national top stories
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
eli lilly
episodic migraine
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
teva pharmaceutical
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
alder biopharmaceuticals
allergy
anaphylaxis
andrew oxtoby
angel investors
What
approval
developed
4
×
fda
4
×
drug
new
won
announced
approved
class
late
medicines
migraine
pain
starts
agency
aimmune
allergy
amgen
ann
arbor
awarded
based
candidates
capital
decision
eli
eye
fifth
friday
gets
head
headache
immunotherapy
lilly
marks
medical
michigan
nod
oral
peanut
Language
unset
Current search:
" national blog main "
×
fda
×
developed
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines